Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Gilead's stock falls as it announces clinical trial for inhaled remdesivir
01:34pm, Monday, 22'nd Jun 2020
Shares of Gilead Sciences Inc. were down 1.2% in trading on Monday after the drugmaker said it plans to start Phase 1 clinical trials for an inhaled version of remdesivir, its treatment for severely
Incyte (INCY) Looks Good: Stock Adds 8.3% in Session
12:36pm, Monday, 22'nd Jun 2020
Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Nasdaq's Excels in Weekly Performance: 5 Best Stocks in ETF
12:05pm, Monday, 22'nd Jun 2020
In a tug of war between bulls and bears, the Dow Jones and S&P 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.
Incyte (INCY) Looks Good: Stock Adds 8.3% in Session
08:36am, Monday, 22'nd Jun 2020
Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
WallStreet : clôture en ordre dispersé 1 trimestre à +35/+40%
09:59pm, Friday, 19'th Jun 2020WallStreet : Clôture en ordre dispersé 1 trimestre à +35/+40%
09:49pm, Friday, 19'th Jun 2020
(CercleFinance.com) - Les jeux étaient fait dès l'ouverture, et c'est souvent le cas à Wall Street lors de la journée des '4 sorcières' : les acheteurs …
S&P 500 top movers: Incyte Corp (INCY) surges above $102, gains nearly 5% | Forex Crunch
04:12pm, Friday, 19'th Jun 2020
Major equity indexes in the US trade in the negative territory. Incyte Corp (INCY) trades at its highest level since early June. Cruise liner stocks
Better Buy: Novartis vs. Teva Pharmaceutical | The Motley Fool
12:17pm, Friday, 19'th Jun 2020
It's a face-off between an incredibly cheap stock and a pharmaceutical giant.
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%
12:00am, Friday, 19'th Jun 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%
Incyte Investor Conference Update
12:00pm, Wednesday, 17'th Jun 2020
Incyte Investor Conference Update.
Strong Retail Sales Bring Third Day of Gains
12:00am, Wednesday, 17'th Jun 2020
Stocks Analysis by Zacks Investment Research covering: Eli Lilly and Company, Bed Bath & Beyond Inc, TJX Companies Inc, Take-Two Interactive Software Inc. Read Zacks Investment Research's latest artic
Lilly launches Phase III study of arthritis drug in Covid-19
01:27pm, Tuesday, 16'th Jun 2020
The company said it had initiated the Phase III study of Olumiant, one of multiple JAK inhibitors that are being tested to find if they can mitigate the cytokine storm associated with Covid-19's worst
Lilly takes AI-selected Olumiant into phase 3 for COVID-19 -
10:39am, Tuesday, 16'th Jun 2020
Eli Lilly takes artificial intelligence-selected Olumiant into phase 3 for COVID-19 as a monotherapy
Coronavirus update: U.S. death toll tops 115,000 amid growing worry about uptick in cases in Florida, Texas among others
04:45pm, Monday, 15'th Jun 2020
The U.S. death toll from the coronavirus illness COVID-19 climbed above 115,000 on Monday, and the stock market tanked amid growing concerns about the uptick in cases in several states after their fir
Oppenheimer Issues a Buy Rating on Incyte (INCY) - Markets
04:07pm, Monday, 15'th Jun 2020
In a report released today, Jay Olson from Oppenheimer assigned a Buy rating to Incyte (INCY – Research Report), with
